This inventor holds 1 USPTO granted patent. Top assignee: Egis Gyogyszergyar Rt.. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: Innovations of Laszlo Koncz in High-Purity Pharmaceutical Processes
Introduction
Laszlo Koncz is a notable inventor based in Magyorod, Hungary, recognized for his significant contributions to pharmaceutical processes. With a focus on enhancing the purity of important compounds, he holds a patent that showcases his innovative methodology in the preparation of high-purity buspirone.
Latest Patents
Koncz's patent involves a sophisticated process for the preparation of high-purity buspirone, along with its hydrochlorides. The invention details a continuous method that includes adding a solution formed with an inert organic solvent and a hydrogenation catalyst. This process aims to achieve optimal purity levels for pharmaceutical applications, which can significantly impact the effectiveness and safety of medication.
Career Highlights
Laszlo Koncz is associated with Egis Gyogyszergyar Rt., a prominent pharmaceutical company in Hungary. His work concentrates on developing advanced methodologies that can improve the quality of pharmaceutical compounds. His dedication to innovation in the field is reflected in the successful patent he holds.
Collaborations
Throughout his career, Koncz has worked alongside accomplished colleagues, including Tibor Mezei and Gabor Blasko. These collaborative efforts signify the importance of teamwork in driving pharmaceutical innovations and improving product quality in the industry.
Conclusion
Laszlo Koncz's patent represents a vital advancement in the pharmaceutical sector, specifically in enhancing the purity of essential compounds like buspirone. His work, supported by an exemplary team at Egis Gyogyszergyar Rt., continues to pave the way for innovations that enhance the efficacy and safety of medications worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
